Confirmatory Study of MCC-847 for the treatment of adult asthma.
Phase 3
- Conditions
- Adult asthma
- Registration Number
- JPRN-jRCT2080220054
- Lead Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Mild to moderate asthmatic patients aged 16 years and older
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy (peak expiratory flow rates) and Safety (adverse events)
- Secondary Outcome Measures
Name Time Method